MDS Treatments

Myelodysplastic syndromes (MDS) are a group of bone marrow disorders where the bone marrow does not produce enough healthy blood cells. Often referred to as “bone marrow failure disorders,” MDS primarily affects older adults. 

Treatment for MDS is personalized and depends on various factors, including the type of MDS, prognostic score, age, overall health, and patient preferences. The main goals of treatment are to manage symptoms, improve quality of life, and increase survival. 

1. Watch and Wait

In some cases, immediate treatment may not be necessary. Patients whose blood counts are not significantly low and who are not experiencing severe symptoms may enter a “watch and wait” period. During this time, their blood levels are closely monitored by their doctor. If blood counts drop or symptoms worsen, treatment can be initiated.

2. Supportive Care

Supportive care aims to alleviate symptoms and improve quality of life without directly treating MDS. It is often the first line of treatment, especially for managing symptoms associated with low blood counts.

• Treating Anemia (Low Red Blood Cell Count):
  • Erythropoiesis-Stimulating Agents (ESAs): Injections of synthetic growth factors like erythropoietin can stimulate the bone marrow to produce more red blood cells.
  • Blood Transfusions: If ESAs are ineffective, red blood cell transfusions may be required. Patients may also receive a cell maturation agent to prolong the time between transfusions.
• Treating Neutropenia (Low White Blood Cell Count):
  • Infection Prevention and Treatment: Patients with low white blood cell counts are more prone to infections. Preventative measures and prompt treatment with antibiotics are essential. In severe cases, white blood cell growth factors may be administered to boost the immune response.
• Treating Thrombocytopenia (Low Platelet Count):
  • Platelet Transfusions and Growth Factors: These may be used to reduce bleeding risks. If standard treatments are ineffective, antifibrinolytic agents, which help reduce bleeding by preventing the breakdown of blood clots, may be used.

3. Chemotherapy for MDS

Chemotherapy targets abnormal stem cells in the bone marrow. The type and intensity of chemotherapy depend on the patient’s goals, overall health, and type of MDS.

• Standard Chemotherapy Drugs:
  • These drugs are designed to attack and destroy MDS cells. High-dose chemotherapy is most often used in younger, healthier patients with high-risk MDS. While effective, these treatments can have severe side effects, including fever, nausea, fatigue, hair loss, and low blood counts.
• Hypomethylating Agents:
  • Drugs like azacitidine (Vidaza) and decitabine (Dacogen and Inqovi) slow the growth of MDS cells by blocking DNA processes that promote cancer cell growth while also encouraging healthy cell development.
• Immunosuppressive Agents:
  • These drugs suppress the immune system to allow stem cells a better chance to grow and produce new blood cells. This approach comes with risks associated with a weakened immune system.
• Immunomodulatory Drugs:
  • Drugs like lenalidomide (Revlimid) help modulate the immune system to target and suppress specific areas, minimizing overall immune suppression.

4. Does Stem Cell Transplant Cure MDS? 

A stem cell transplant (SCT), also known as a bone marrow transplant, is currently the only potential cure for MDS. It involves replacing the diseased bone marrow with healthy stem cells from a donor. This treatment is typically reserved for younger, healthier patients due to its complexity and risks.

• Allogeneic SCT: Involves stem cells from a donor, ideally a close relative with a matching HLA type. This treatment includes high-dose chemotherapy to destroy the patient’s bone marrow, followed by the infusion of healthy donor stem cells.
• Side Effects and Risks:
  • Severe side effects include mouth sores, vomiting, hair loss, low blood counts, and a risk of graft-versus-host disease (GVHD), where the new immune system attacks the patient’s tissues. GVHD can be life-threatening and requires careful monitoring.

5. Clinical Trials for Treating MDS 

Participating in a clinical trial can provide access to new and emerging treatments that are not yet widely available. Clinical trials are an essential part of the research process and contribute to the development of new therapies for MDS.

Receiving a Myelodysplastic Syndromes (MDS) diagnosis can be overwhelming, but it’s important to remember that there are many treatment options available. Work closely with your doctor to explore these options, understand the potential side effects, and determine the best course of action for your individual situation. Early and appropriate treatment can help manage symptoms, improve quality of life, and increase survival.

Join HealthTree Cure Hub and Become a Cure Contributor ​​

Accelerate the discovery of new treatment options by connecting your records to HealthTree Cure Hub, an innovative tool that powers life-saving research!

If you are interested in participating in or finding a clinical trial, locating an MDS specialist, or staying informed about updates on MDS with a biweekly newsletter, you can create a free HealthTree Cure Hub account!

CREATE YOUR FREE ACCOUNT